ATE236612T1 - Behandlung zur zerstörung einer barriereschicht in strukturell geschädigter haut - Google Patents

Behandlung zur zerstörung einer barriereschicht in strukturell geschädigter haut

Info

Publication number
ATE236612T1
ATE236612T1 AT96936785T AT96936785T ATE236612T1 AT E236612 T1 ATE236612 T1 AT E236612T1 AT 96936785 T AT96936785 T AT 96936785T AT 96936785 T AT96936785 T AT 96936785T AT E236612 T1 ATE236612 T1 AT E236612T1
Authority
AT
Austria
Prior art keywords
destroy
treatment
barrier layer
damaged skin
structurally damaged
Prior art date
Application number
AT96936785T
Other languages
English (en)
Inventor
Walter P Smith
Original Assignee
Mary Kay Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mary Kay Inc filed Critical Mary Kay Inc
Application granted granted Critical
Publication of ATE236612T1 publication Critical patent/ATE236612T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/68—Sphingolipids, e.g. ceramides, cerebrosides, gangliosides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT96936785T 1995-10-18 1996-10-17 Behandlung zur zerstörung einer barriereschicht in strukturell geschädigter haut ATE236612T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/544,713 US5720963A (en) 1994-08-26 1995-10-18 Barrier disruption treatments for structurally deteriorated skin
PCT/US1996/016844 WO1997014403A1 (en) 1995-10-18 1996-10-17 Barrier disruption treatments for structurally deteriorated skin

Publications (1)

Publication Number Publication Date
ATE236612T1 true ATE236612T1 (de) 2003-04-15

Family

ID=24173263

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96936785T ATE236612T1 (de) 1995-10-18 1996-10-17 Behandlung zur zerstörung einer barriereschicht in strukturell geschädigter haut

Country Status (12)

Country Link
US (1) US5720963A (de)
EP (1) EP0855904B1 (de)
CN (1) CN1108146C (de)
AR (1) AR005234A1 (de)
AT (1) ATE236612T1 (de)
AU (1) AU7461996A (de)
BR (1) BR9611024A (de)
CA (1) CA2234975A1 (de)
DE (1) DE69627360D1 (de)
RU (1) RU2170574C2 (de)
TW (1) TW537900B (de)
WO (1) WO1997014403A1 (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5720963A (en) * 1994-08-26 1998-02-24 Mary Kay Inc. Barrier disruption treatments for structurally deteriorated skin
EP1037623A1 (de) * 1997-12-12 2000-09-27 Warner-Lambert Company Hypolipaemische kombinationen aus statin und lp(a)-inhibitoren
US6290659B1 (en) 1999-03-27 2001-09-18 John M. Hill Skin exfoliation method and apparatus
US6495126B1 (en) 1999-07-20 2002-12-17 Mary Kay Inc. Treatment and composition for achieving skin anti-aging benefits by corneum protease activation
US6645184B1 (en) 1999-08-09 2003-11-11 Brian D. Zelickson Tape stripping system and method
US7354423B2 (en) * 1999-08-09 2008-04-08 J&J Consumer Co., Inc. Skin abrasion system and method
US6563012B2 (en) * 1999-09-28 2003-05-13 John M Hill Skin exfoliation apparatus and method
US6824785B1 (en) 2000-02-09 2004-11-30 C. Neil Kitson Skin treatment composition and methods of use
FR2806301B1 (fr) * 2000-03-20 2002-10-31 Led Evolution Dermatolog Composition a base de sphingolipide et de beta-hydroxy-acide utilisable par voie topique pour les soins de la peau
MC200029A1 (fr) * 2001-04-19 2001-11-28 Jose Eisenberg Application de trois molecules
US6929800B2 (en) 2001-08-06 2005-08-16 Abdul Rasoul Salman Nasal passage cleaning composition
RU2203023C1 (ru) * 2002-05-24 2003-04-27 Горчак Александр Владимирович Бальзам-гель "русская баня" от целлюлита
US7238370B2 (en) * 2002-06-14 2007-07-03 Rosenberg E William Method and composition to prevent and treat photoaging of skin
WO2004017972A1 (en) * 2002-08-23 2004-03-04 Law Peter K Biologic skin repair and enhancement
JP4684655B2 (ja) * 2002-12-18 2011-05-18 ラボラトワール ブザン アンテルナスィヨナル ４−ヒドロキシタモキシフェンによる乳房密度低下
WO2004054557A2 (en) * 2002-12-18 2004-07-01 Laboratoires Besins International Treatment of mastalgia with 4-hydroxy tamoxifen
US20040126449A1 (en) * 2002-12-30 2004-07-01 Gopa Majmudar Topical composition and methods for treatment of aged or environmentally damaged skin
US20070243271A1 (en) * 2003-01-13 2007-10-18 Steven Hernandez Use of polyphenols to treat skin conditions
CA2519980C (en) * 2003-04-01 2012-04-10 Laboratoires Besins International Prevention and treatment of breast cancer with 4-hydroxy tamoxifen
US7767717B2 (en) * 2003-06-09 2010-08-03 Ascend Therapeutics, Inc. Treatment and prevention of excessive scarring with 4-hydroxy tamoxifen
US20050106194A1 (en) * 2003-11-18 2005-05-19 Mary Kay Inc. Compositions for achieving benefits in skin using key cellular metabolic intermediates
US7025966B2 (en) 2003-12-05 2006-04-11 Mary Kay Inc. Compositions of marine botanicals to provide nutrition to aging and environmentally damaged skin
US7968532B2 (en) * 2003-12-15 2011-06-28 Besins Healthcare Luxembourg Treatment of gynecomastia with 4-hydroxy tamoxifen
US20050143754A1 (en) * 2003-12-31 2005-06-30 Zelickson Brian D. Skin abrasion system and method
US20050158258A1 (en) * 2004-01-21 2005-07-21 Mary Kay Inc. Methods and compositions for the treatment of skin changes associated with aging and environmental damage
US7507769B2 (en) * 2004-03-22 2009-03-24 Laboratoires Besins International Treatment and prevention of benign breast disease with 4-hydroxy tamoxifen
WO2007019048A2 (en) * 2005-08-02 2007-02-15 Mary Kay Inc. High ph compositions
GB0525680D0 (en) 2005-12-16 2006-01-25 Peplin Ltd Therapeutic compositions
EP1981513B1 (de) 2006-01-19 2015-05-27 Mary Kay, Inc. Zusammensetzungen mit kakadupflaumenextrakt oder assaibeerenextrakt
US20070224154A1 (en) * 2006-03-21 2007-09-27 Access Business Group International, Llc Methods of reducing skin irritation
EP2455134B1 (de) 2007-04-19 2016-05-11 Mary Kay, Inc. Magnolienextrakthaltige Zusammensetzungen
RU2410079C1 (ru) * 2009-05-20 2011-01-27 Закрытое акционерное общество "Косметический центр "ЛАКРИМА" Способ ухода за кожей вокруг глаз
US8048456B2 (en) 2009-08-28 2011-11-01 Mary Kay Inc. Skin care formulations
RU2455969C1 (ru) * 2011-04-21 2012-07-20 Жанна Кахрамоновна Архангельская Способ пластического омоложения лица
CN105362210A (zh) * 2015-11-19 2016-03-02 朱坤福 一种疤痕凝胶及其制备方法
WO2022131141A1 (en) * 2020-12-14 2022-06-23 L'oreal Multi-phase composition comprising alpha hydroxy acid
FR3118872B1 (fr) * 2021-01-15 2024-02-02 Oreal Composition multiphasique comprenant un alpha-hydroxyacide

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4363815A (en) * 1975-07-23 1982-12-14 Yu Ruey J Alpha hydroxyacids, alpha ketoacids and their use in treating skin conditions
US5091171B2 (en) * 1986-12-23 1997-07-15 Tristrata Inc Amphoteric compositions and polymeric forms of alpha hydroxyacids and their therapeutic use
US5389677B1 (en) * 1986-12-23 1997-07-15 Tristrata Inc Method of treating wrinkles using glycalic acid
US4983382A (en) * 1987-01-27 1991-01-08 Avon Products, Inc. Cosmetic preparation incorporating stabilized ascorbic acid
US5190876A (en) * 1988-12-27 1993-03-02 Emory University Method of modifying cellular differentiation and function and compositions therefor
US5051449A (en) * 1991-02-27 1991-09-24 Kligman Albert M Treatment of cellulite with retinoids
US5215759A (en) * 1991-10-01 1993-06-01 Chanel, Inc. Cosmetic composition
US5391373A (en) * 1992-07-01 1995-02-21 Chanel, Inc. Skin cream composition
CA2099188C (en) * 1992-07-24 2005-12-13 Paul A. Bowser Use of a cosmetic composition
RU2113216C1 (ru) * 1992-09-14 1998-06-20 П.Смит Уолтер Косметический состав (варианты)
EP0716589A4 (de) * 1993-07-23 1997-06-11 Morris Herstein Kosmetische, die hauterneuerung stimulierende zusammensetzung mit langzeit-irritationskontrolle
AU7532794A (en) * 1993-07-26 1995-02-20 Unilever Plc Cosmetic composition containing alpha hydroxy acids
US5401517A (en) * 1993-11-15 1995-03-28 Elizabeth Arden Company, Division Of Conopco, Inc. Cosmetic method for treatment of skin
JP3434333B2 (ja) * 1993-11-08 2003-08-04 株式会社ノエビア 皮膚外用剤
US5382432A (en) * 1993-11-15 1995-01-17 Elizabeth Arden Company, Division Of Conopco, Inc. Cosmetic method for treatment of skin
FR2718022B1 (fr) * 1994-04-01 1996-04-26 Roussel Uclaf Compositions cosmétiques ou dermatologiques et leur préparation.
JP3212800B2 (ja) * 1994-07-14 2001-09-25 三菱電機株式会社 車載用充電装置
US5720963A (en) * 1994-08-26 1998-02-24 Mary Kay Inc. Barrier disruption treatments for structurally deteriorated skin
US5587396A (en) * 1994-08-26 1996-12-24 Mary Kay Inc. Method of ameliorating cellulite by disrupting the barrier function of the stratum corneum
US5476661A (en) * 1994-10-21 1995-12-19 Elizabeth Arden Co., Division Of Conopco, Inc. Compositions for topical application to skin, hair and nails
EP0866693B1 (de) * 1995-10-18 2003-08-20 Mary Kay Inc. Topisch angewandte strukturelle behandlungen der zellulitis

Also Published As

Publication number Publication date
CN1108146C (zh) 2003-05-14
BR9611024A (pt) 1999-07-13
DE69627360D1 (de) 2003-05-15
CN1202817A (zh) 1998-12-23
EP0855904B1 (de) 2003-04-09
WO1997014403A1 (en) 1997-04-24
RU2170574C2 (ru) 2001-07-20
EP0855904A1 (de) 1998-08-05
US5720963A (en) 1998-02-24
AU7461996A (en) 1997-05-07
AR005234A1 (es) 1999-04-28
CA2234975A1 (en) 1997-04-24
TW537900B (en) 2003-06-21

Similar Documents

Publication Publication Date Title
ATE236612T1 (de) Behandlung zur zerstörung einer barriereschicht in strukturell geschädigter haut
FI972580A7 (fi) Valmisteita ja menetelmiä ihoärsytyksen vähentämiseksi
FI964921A7 (fi) Ihopinnan kuorintamenetelmä käyttäen laaseria
IT1283443B1 (it) Dispositivo e metodo per rinforzare punti chirurgici
DE69618188D1 (de) Kosmetisches hautbehandlungsverfahren
HU9600596D0 (en) Method of treating cardiac in flammatory disease
EP0871705A4 (de) Menschlicher ccn-ähnlicher wachstumsfaktor
DE69519372D1 (de) Hautreinigungsmittel
ATE251444T1 (de) Verminderung des haarwuchses
ID22061A (id) Metoda perawatan pigmentasi kulit
ATE209890T1 (de) Verminderung des haarwuchses
FI973468L (fi) Hampaiden valkaisemiseen tai ihon ja limakalvojen sairauksien hoitoon käytettävien valmisteiden valmistusmenetelmä
DE69524138D1 (de) Hautbehandlungsmittel
BR9603431A (pt) Método para tratar privação de abuso de substância
FI963687A7 (fi) Hygieeniset ja kosmeettiset valmisteet ihosairauksien estämiseksi ja h oitamiseksi sekä menetelmä niiden valmistamiseksi
FI951060L (fi) Formulaatioita ja hoitomenetelmiä
GB9523335D0 (en) Improvements in or relating to skin treatment materials
ATE397913T1 (de) Damenbinde mit seitensperren zur lecksicherung
DE69502704D1 (de) Hautreinigungsmittel
FI953709L (fi) Menetelmä hiusten kasvun edistämiseksi
DE69528637D1 (de) Hautbehandlungsmittel gegen akne
DE69505617D1 (de) Oberflächenbehandlung eines Einkristalls aus LnBa2Cu3O7-x-Oxid
DE69614890D1 (de) Hautstreckmaschine
EP0840605A4 (de) Verbindungen zur verwendung in der behandlung von neurofibromatose
DE69811441D1 (de) Behandlungsverfahren zur Reduzierung der Oberflächenenergie

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties